Behavioral Therapy for Insomnia in Concussions
Trial Summary
What is the purpose of this trial?
This is a single site, two-armed random controlled trials (RCT) comparing six sessions of Cognitive Behavioral Therapy for Insomnia (CBT-I) with four sessions of Brief Behavioral Therapy for Insomnia (BBT-I) in service members with comorbid insomnia and prolonged postconcussive symptoms present for at least 3 months after Mild Traumatic Brain Injury (mTBI).
Will I have to stop taking my current medications?
The trial requires that participants be stable on their current psychotropic and hypnotic medications for at least 1 month before joining. This means you should not change these medications right before or during the trial.
What data supports the effectiveness of the treatment for insomnia in concussions?
Research shows that cognitive-behavioral therapy for insomnia (CBT-I) is effective in treating insomnia, including in cases related to traumatic brain injury (TBI). Brief Behavioral Therapy for Insomnia (BBTI) has also been shown to reduce insomnia symptoms and is effective in various settings, making it a promising option for those with sleep issues after a concussion.12345
Is behavioral therapy for insomnia safe for humans?
How is the treatment for insomnia in concussions unique?
The treatment uses Cognitive Behavioral Therapy for Insomnia (CBT-I), which is a non-drug approach that focuses on changing sleep habits and behaviors to improve sleep. It is unique because it addresses insomnia specifically in the context of concussions, potentially improving not just sleep but also related symptoms like mood and pain.12389
Research Team
Kristi E Pruiksma, PhD
Principal Investigator
The University of Texas Health Science Center at San Antonio
Eligibility Criteria
This trial is for active duty U.S. military service members aged 18 or older who have had a mild traumatic brain injury at least 3 months ago and are experiencing insomnia. They must be able to consent, follow instructions, stay in the area for 3 months, and have stable medication use if applicable.Inclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Cognitive Behavioral Therapy for Insomnia (CBT-I) or Brief Behavioral Therapy for Insomnia (BBT-I) with sessions delivered in-person or via telehealth
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Brief Behavioral Therapy for Insomnia (Behavioral Intervention)
- Cognitive Behavioral Therapy for Insomnia (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center at San Antonio
Lead Sponsor
Dr. Andrew Masica
The University of Texas Health Science Center at San Antonio
Chief Medical Officer
MD from Indiana University School of Medicine
Dr. Taylor Eighmy
The University of Texas Health Science Center at San Antonio
Acting President
PhD in Civil Engineering from the University of New Hampshire
Congressionally Directed Medical Research Programs
Collaborator
Colonel Mark G. Hartell
Congressionally Directed Medical Research Programs
Director, Congressionally Directed Medical Research Programs since 2022
PhD in Analytical Chemistry from Auburn University, MS in Biophysical Chemistry from Ohio State University, BS in Chemistry from State University of New York at Oswego
Dr. Sarah Goldman
Congressionally Directed Medical Research Programs
Chief Medical Officer since 2023
MD
Hope Health Research Institute
Collaborator